Officials in Ontario and Quebec say the subvariants are helping fuel a new wave – the seventh so far. But are BA.4 and BA.5 more dangerous?
As with previous versions of the virus, the concern is that while widespread transmission will produce relatively mild disease in most people, the absolute number of people who need be hospitalized or who die will necessarily grow.
Evidence from South Africa suggests BA.4 and BA.5 are not causing a worrying surge in hospitalizations, but in Portugal the rise in hospitalization and death is similar to previous Omicron surges.Public health officials in Canada have not called for a return to any kind of forced restriction in our daily lives, or of vaccine and mask mandates.Health officials are unanimous about the first and best way to fight BA.4 and BA.5 — get booster shots of vaccine.
Public health doctors also recommend that people wear masks while indoors among large groups of people, and favour outdoor gatherings if possible.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
What we know about BA.4 and BA.5 — the latest subvariants to cause COVID surgeOfficials in Ontario and Quebec say the subvariants are helping fuel a new wave – the seventh so far. But are BA.4 and BA.5 more dangerous?
Read more »
What we know about BA.4 and BA.5 — the latest subvariants to cause COVID surgeOfficials in Ontario and Quebec say the subvariants are helping fuel a new wave – the seventh so far. But are BA.4 and BA.5 more dangerous?
Read more »
China's Shanghai says new Omicron subvariant foundSHANGHAI — The city of Shanghai has discovered a COVID\u002D19 case involving a new subvariant Omicron BA.5.2.1, an official told a briefing on Sunday, signaling…
Read more »
COVID: China's Shanghai says new Omicron subvariant foundThe city of Shanghai has discovered a COVID-19 case involving a new subvariant Omicron BA.5.2.1, an official told a briefing on Sunday, signaling the complications China faces to keep up with new mutations as it pursues its 'zero-COVID' policy.
Read more »